Kennedy Krieger Institute is looking for children, ages 5 through 13 years, with fragile X syndrome to participate in a research study.
Double Blind trial of Roche mGluR5 Antagonist RO4917523
PROCEDURES: Participation in this study will require up to 9 visits (each lasting 2-10 hours) to the Kennedy Krieger Institute in Baltimore, MD and up to 10 between-visit phone calls with the study doctor over an 18-week period.
Eligible participants may receive reimbursement for time and travel. The investigational drug and all study-related evaluations are provided at no cost to the participants.
Interested? Study Coordinator: 443-923-7619 or ResearchTrials@kennedykreiger.org